Post Offer Free
Wuhan Yuancheng Gongchuang Technology Co,ltd
Wuhan Yuancheng Gongchuang Technology Co,ltd

China Cabozantinib Pharmaceutical Raw Materials Cabozantinib 849217-68-1 Cabozantinib manufacturer


Gold Index: 167644

You are here: home  > Pharmaceutical raw material  > Other pharmaceuticals  > Cabozantinib Pharmaceutical Raw Materials Cabozantinib 849217-68-1 Cabozantinib

Cabozantinib Pharmaceutical Raw Materials Cabozantinib 849217-68-1 Cabozantinib 

Price: 90.0 USD 
Payment Terms: T/T,D/A,WU,Money Gram;Bitcoin 
Place of Origin: Hubei, China (Mainland) 
inquire skype
Add to My Favorites
HiSupplier Escrow
Share |

Product Detail

Model No.: C28H24FN3O5
Production Capacity: 500kg//month
Delivery Date: 4-15days
CAS No.: 849217-68-1
Alias: Cabozantinib
usage: Cabozantinib
price: Cabozantinib price
effects: Cabozantinib
Appearance: Cabozantinib powder
Means of Transport: Ocean,Air;Express
Packing: disguise package or as requ...
Brand Name: gongchuang
Purity: 99%
source: Cabozantinib from China
supplier: Cabozantinib supplier
Usage: Cabozantinib for medical
purity: 99% Cabozantinib
Standard: USP/BP/USP Cabozantinib

cabozantinib powder;cabozantinib source; cabozantinib factory;
cabozantinib for sale; cabozantinib supplier;
cabozantinib anti-cancer

USP Effectual Apis Cabozantinib 849217-68-1 XL184 for Thyroid Cancer Treatment

Pharmaceutical Raw Powder Cabozantinib (XL184) for Cancer Research CAS: 849217-68-1

Pharmaceutical Intermediates Raw Materials Cabozantinib CAS 849217-68-1

Cabozantinib, marketed under the trade name Cabometyx among others, is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and has been shown to reduce tumor growth, metastasis, and angiogenesis. It was discovered and developed by Exelixis Inc.

Cabozantinib was granted orphan drug status by the U.S. Food and Drug Administration (FDA) in January 2011.Cabozantinib is approved by the U.S. FDA for medullary thyroid cancer.and advanced renal cell carcinoma in people who have received prior anti-angiogenic therapy.It is currently undergoing clinical trials for the treatment of prostate, bladder, ovarian, brain, melanoma, breast, non-small cell lung, pancreatic, and hepatocellular cancers.

Cabozantinib will be distributed in Europe by the French pharmaceutical company Ipsen after a collaboration was reached with Exelixis in March 2016.

Cabozantinib Profile

Product Name: Cabozantinib

Cabozantinib Synonyms: N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;Cabozantinib;N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;XL184;Cabozantinib(XL184);XL-184 free base (Cabozantinib);BMS907351;N-(4-((6,7-DiMethoxyquino...

Cabozantinib CAS: 849217-68-1

Cabozantinib MF: C28H24FN3O5

Cabozantinib MW: 502

Cabozantinib EINECS:205-285-7    

Cabozantinib Product Categories: Inhibitors

Mol File: 849217-68-1.mol

Cabozantinib Description

Anti-cancer drug    Cabozantinib is a kind of a novel type of molecular targeted drug developed by the United States Exelixis biopharmaceutical company. On November 29, 2012, the US Food and Drug Administration (FDA) approved the use of cabozantinib for the treatment of unresectable malignant local advanced or metastatic medullary thyroid carcinoma.

In addition, Sorafenib, Vandernib and Levotinib have been approved by the Food and Drug Administration (FDA) for the treatment of advanced thyroid cancer.

Cabozantinib Usage    

Uses and fuction:

Cabozantinib interferes with the growth of some cancer cells.

Cabozantinib is used to treat thyroid cancer that has spread to other parts of the body.

Cabozantinib is also used to treat kidney cancer after other cancer medicines have been tried without success.

Cabozantinib may also be used for purposes not listed in this medication guide.


Tests Specifications Results
CharactersWhite to off-white crystalline powder with a characteristic
 sulfide-like order  
IdentificationIR:similar to Reference StandardComplies
Appearance of solutionClear and colorlessComplies
Specific Rotation-127° -132°-131°
Loss on Drying<0.5%0.06%
Sulphated Ash<0.2%0.03%
Heavy metals<0.002%Complies
pH2.0 to 2.62.3
Related Compouds1. 1.    Single Impurity <1.0% 2. 2.    Sum of Impurity<2.0%Undetected Undetected
Assay(Anhydrous)98.0% to 101.5%100.2%

Ms. Gina
skype Ms. Gina
Tel: 86-27-88211875
Mobile: 188 7222 0799
Contact to this supplier

Didn't find what you're looking for? Post Buying Lead or contact HiSupplier Customer Service Center  for help!

Related Search

Find more related products in following catalogs on

Other products from this supplier

Company Info

Wuhan Yuancheng Gongchuang Technology Co,ltd [China (Mainland)]

Business Type:Manufacturer, Trading Company
City: Wuhan
Province/State: Hubei
Country/Region: China (Mainland)

Follow Us: Follow us on facebook Follow us on linkedin Follow us on Twitter

Gina:   skype
Service:   skype

You May Like: